Status:
COMPLETED
French Memory Support System: A Pilot Study
Lead Sponsor:
Bruyère Health Research Institute.
Collaborating Sponsors:
Ottawa Hospital Research Institute
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop a linguistically and culturally appropriate adaptation of the Memory Support System (MSS), an evidence-based intervention to train persons with mild cognitive i...
Detailed Description
At enrollment, participants with MCI and their care partners will complete French measures evaluating cognitive and functional status. Participants and partners will also complete French measures of t...
Eligibility Criteria
Inclusion
- diagnosis of single or multi-domain MCI
- Clinical Dementia Rating global (CDR) score of ≤ 0.5
- Dementia Rating Scale-Second edition score of ≥ 115
- available contact with a care partner ≥ 2 times weekly
- absence or stable intake of nootropic(s) for ≥ 3 months
Exclusion
- visual/hearing impairment and/or history of reading or written inability/disability sufficient to interfere with MSS training
- concurrent participation in another related clinical trial
Key Trial Info
Start Date :
March 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05253365
Start Date
March 3 2022
End Date
March 31 2023
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bruyere Research Institute
Ottawa, Ontario, Canada, K1H 5C8